Pathophysiological Rationale For The Use Of A New Amino Acid Mixture For Liver Damage

Sayfutdinova, Z.A.; Kurbonova, Z.Ch.; Sadikova, N.M.; Gulyamov, N.G.; Erdogan, Filiz M.; Xashimova, G.

dc.contributor.author	Sayfutdinova, Z.A.
dc.contributor.author	Kurbonova, Z.Ch.
dc.contributor.author	Sadikova, N.M.
dc.contributor.author	Gulyamov, N.G.
dc.contributor.author	Erdogan, Filiz M.
dc.contributor.author	Xashimova, G.
dc.date.accessioned	2023-05-02T18:40:47Z
dc.date.available	2023-05-02T18:40:47Z
dc.date.issued	2023-04
dc.identifier.issn	2660-5589
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7395
dc.description.abstract	The main causes of chronic hepatitis and liver cirrhosis is infection with hepatitis B and C. The most dangerous types of hemotransmissive infections include hepatitis B, C and D. At the same time, more than 180 hepatotoxic drugs have been identified, of which 6 groups seriously injure the liver. At the same time, 50% of drugs are hepatotoxic, especially in women this effect is more pronounced	en_US
dc.language.iso	en	en_US
dc.publisher	European Journal of Humanities and Educational Advancements	en_US
dc.relation.ispartofseries	4;
dc.subject	Pathophysiological rationale, new amino acid mixture, liver damage	en_US
dc.title	Pathophysiological Rationale For The Use Of A New Amino Acid Mixture For Liver Damage	en_US
dc.type	Article	en_US